Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nicholas P McAndrew, MD
UCLA / Jonsson Comprehensive Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Joseph Heritage Healthcare
Fullerton, California, United States
William E. Lawler, M.D.Recruiting - Cancer Blood and Specialty Clinic
Los Alamitos, California, United States
Vu Phan, M.D.Recruiting - Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
Nicholas P McAndrew, M.D.Recruiting - Torrance Memorial Physician Network / Cancer Care
Torrance, California, United States
David Chan, M.D.Recruiting - Pih Health
Whittier, California, United States
Lisa Shing-E Lu Wang, M.D.Recruiting - Orlando Health, Inc. D/b/a Orlando Health Uf Health Center
Orlando, Florida, United States
Withdrawn - Ft. Wayne Medical Oncology and Hematology, Inc.
Fort Wayne, Indiana, United States
Withdrawn - Cancer Center of Kansas
Wichita, Kansas, United States
Shaker Dakhil, M.D.Recruiting - Massachusetts General Hospital
Boston, Massachusetts, United States
Laura M Spring, M.D.Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Oct 2020
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 10 Nov 2025
- Registered enrollment
- 88
- Registry id
- NCT04553770
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.